公司概覽
業務類別 --
業務概覽 Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.
公司地址 Ideon Science Park, Lund, SWE, SE-223 70
電話號碼 +46 462865730
傳真號碼 +46 462865739
公司網頁 https://www.camurus.com
員工數量 256
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Fredrik Tiberg Director, President, Chief Scientific Officer and Chief Executive Officer -- 30/04/2025
Mr. Jon Garay Alonso Chief Financial Officer -- 30/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Per Olof Wallstrom Chairman of the Board 30/04/2025
Mr. Fredrik Tiberg Director, President, Chief Scientific Officer and Chief Executive Officer 30/04/2025
Ms. Hege Hellstrom Independent Director 30/04/2025
Mr. Jakob Lindberg Independent Director 30/04/2025
Mr. Stefan K Persson Independent Director 30/04/2025
Ms. Erika Soderberg Johnsson Independent Director 30/04/2025
 
所屬ETF (更新日期: 07/03/2026 02:32)
代號 名稱 佔比% 持有日期
FPXEFirst Trust IPOX Europe Equity Opps ETF<0.000001%21/12/2025
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%27/02/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.